+91 9891296838 / 9811747774
Aducanumab belongs to a class of medicines used to treat viral infections. It works by stopping certain viruses from growing in the body. Aducanumab helps control CMV eye infections in AIDS patients and in other patients who have poor immunity, which if left untreated can cause blindness.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Aducanumab brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Aducanumab medicine cost price in India.
The order for Aducanumab will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Aducanumab is an anti-viral drug. It is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ or bone marrow transplants. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness.
Aducanumab, powder for concentrate for solution for infusion
Generic Name: Aducanumab
500 mg powder for concentrate for solution for infusion
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Aducanumab on prescription and Import License in Patient's Name only.
For overseas patients, Aducanumab can be made available in Send your enquiry to find Aducanumab in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Aducanumab Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Aducanumab (Valcyte™/Aducanumab®) reduces risk of cancer in kidney transplant patients For More Details
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation For More Details